Compare Ikapharmindo Putramas Tbk. (IKPM) vs Reksa Dana Indeks BNP Paribas IDX Growth30 ETF (XBIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ikapharmindo Putramas Tbk. vs Reksa Dana Indeks BNP Paribas IDX Growth30 ETF — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 313.35B, 1.41M 24h volume), while Reksa Dana Indeks BNP Paribas IDX Growth30 ETF trades at Rp600 (market cap 120M). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 2611.3× Reksa Dana Indeks BNP Paribas IDX Growth30 ETF's market cap. Which is the better fit depends on your goals.
| IKPM | XBIG | |
|---|---|---|
Market Cap | 313.35B | 120M |
Volume | 1.41M | — |
Lot | 14.1K | — |
Turnover | 271.25M | — |
Average Price | 192.33 | — |
Value | 271.25M | — |
Indicative Equilibrium Price | 186 | — |
Indicative Equilibrium Volume | 600 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →
